Summarizing the results, we demonstrated that general symptoms of LC at month six were associated statistically significantly with an increase in uPA (plasminogen activator) and with more severe COV in the acute phase of the infection. The gene discussed is PLAU; the disease is laryngotracheoesophageal cleft.